Related Experiment Video
Updated: Apr 21, 2026
05:52
Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
25.1K
Alteplase in acute ischemic stroke: putting the guidelines into practice
Nandakumar Nagaraja1, Harold P Adams
1Division of Cerebrovascular Diseases, Department of Neurology, University of Iowa Carver College of Medicine, 200 Hawkins Drive, 2148 RCP, Iowa City, IA, 52242, USA.
CNS Drugs
|October 20, 2014
Summary
Recombinant tissue plasminogen activator (rt-PA) is the sole approved treatment for acute ischemic stroke within 3 hours. This review covers its FDA approval, extended use, and future stroke therapies.
Area of Science:
- Neurology
- Emergency Medicine
- Pharmacology
Background:
- Acute ischemic stroke requires rapid intervention.
- Intravenous recombinant tissue plasminogen activator (rt-PA) is the primary medical treatment.
- Timeliness is critical for effective stroke management.
Purpose of the Study:
- To review pivotal studies leading to rt-PA FDA approval for acute ischemic stroke within 3 hours.
- To discuss rt-PA use beyond the 3-hour window.
- To explore future reperfusion therapies and stroke care systems.
Main Methods:
- Review of preliminary clinical studies on rt-PA efficacy.
- Analysis of US FDA approval data for rt-PA.
- Discussion of existing and emerging stroke treatment paradigms.
Main Results:
- Preliminary studies supported rt-PA's efficacy within 3 hours of symptom onset.
- FDA approval established rt-PA as a standard of care for early ischemic stroke.
- Ongoing research explores extended therapeutic windows and novel reperfusion strategies.
Conclusions:
- Early administration of rt-PA is crucial for acute ischemic stroke treatment.
- Further research is needed to optimize rt-PA use and develop advanced reperfusion therapies.
- Comprehensive stroke systems of care enhance patient outcomes.
Related Concept Videos
01:15Ischemic Stroke l: Introduction
9
Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
9
01:16Clot Retraction and Fibrinolysis
5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
01:26Transient Ischemic Attack l: Introduction
4
A transient ischemic attack (TIA) is a brief episode of neurological dysfunction caused by a temporary, focal reduction in cerebral blood flow. Although symptoms resemble those of an ischemic stroke, the interruption in perfusion is short-lived and does not cause permanent infarction. TIAs are clinically important because they often serve as early warning events for future stroke.Mechanisms of Transient Cerebral IschemiaTransient cerebral ischemia may arise through several mechanisms. One...
4
01:15Ischemic Stroke ll: Pathophysiology
5
An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
5
01:29Venous Thrombosis III: Interprofessional Care
480
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
480
01:22Formation of the Platelet Plug
6.0K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.0K